These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 33426702)

  • 1. Adoptive transfer of immunomodulatory M2 macrophages suppresses experimental autoimmune encephalomyelitis in C57BL/6 mice via blockading NF-κB pathway.
    Chu F; Shi M; Lang Y; Chao Z; Jin T; Cui L; Zhu J
    Clin Exp Immunol; 2021 May; 204(2):199-211. PubMed ID: 33426702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adoptive transfer of cytokine-induced immunomodulatory adult microglia attenuates experimental autoimmune encephalomyelitis in DBA/1 mice.
    Zhang XM; Lund H; Mia S; Parsa R; Harris RA
    Glia; 2014 May; 62(5):804-17. PubMed ID: 24677019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mdivi-1 Modulates Macrophage/Microglial Polarization in Mice with EAE via the Inhibition of the TLR2/4-GSK3β-NF-κB Inflammatory Signaling Axis.
    Liu X; Zhang X; Niu X; Zhang P; Wang Q; Xue X; Song G; Yu J; Xi G; Song L; Li Y; Ma C
    Mol Neurobiol; 2022 Jan; 59(1):1-16. PubMed ID: 34618332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protecting effect of emodin in experimental autoimmune encephalomyelitis mice by inhibiting microglia activation and inflammation via Myd88/PI3K/Akt/NF-κB signalling pathway.
    Zheng K; Lv B; Wu L; Wang C; Xu H; Li X; Wu Z; Zhao Y; Zheng Z
    Bioengineered; 2022 Apr; 13(4):9322-9344. PubMed ID: 35287559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ginsenoside-Re inhibits experimental autoimmune encephalomyelitis as a mouse model of multiple sclerosis by downregulating TLR4/MyD88/NF-κB signaling pathways.
    Oh J; Kwon TW; Choi JH; Kim Y; Moon SK; Nah SY; Cho IH
    Phytomedicine; 2024 Jan; 122():155065. PubMed ID: 37856989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paricalcitol improves experimental autoimmune encephalomyelitis (EAE) by suppressing inflammation via NF-κB signaling.
    Zhang D; Qiao L; Fu T
    Biomed Pharmacother; 2020 May; 125():109528. PubMed ID: 32106388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclic AMP Pathway Suppress Autoimmune Neuroinflammation by Inhibiting Functions of Encephalitogenic CD4 T Cells and Enhancing M2 Macrophage Polarization at the Site of Inflammation.
    Veremeyko T; Yung AWY; Dukhinova M; Kuznetsova IS; Pomytkin I; Lyundup A; Strekalova T; Barteneva NS; Ponomarev ED
    Front Immunol; 2018; 9():50. PubMed ID: 29422898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel disease-modifying anti-rheumatic drug iguratimod suppresses chronic experimental autoimmune encephalomyelitis by down-regulating activation of macrophages/microglia through an NF-κB pathway.
    Li G; Yamasaki R; Fang M; Masaki K; Ochi H; Matsushita T; Kira JI
    Sci Rep; 2018 Jan; 8(1):1933. PubMed ID: 29386552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrophage Plasticity and Polarization Are Altered in the Experimental Model of Multiple Sclerosis.
    Leuti A; Talamonti E; Gentile A; Tiberi M; Matteocci A; Fresegna D; Centonze D; Chiurchiù V
    Biomolecules; 2021 Jun; 11(6):. PubMed ID: 34200023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel PADRE-Kv1.3 vaccine effectively induces therapeutic antibodies and ameliorates experimental autoimmune encephalomyelitis in rats.
    Fan C; Long R; You Y; Wang J; Yang X; Huang S; Sheng Y; Peng X; Liu H; Wang Z; Liu K
    Clin Immunol; 2018 Aug; 193():98-109. PubMed ID: 29496642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential role of BAY11-7082, a NF-κB blocker inhibiting experimental autoimmune encephalomyelitis in C57BL/6J mice via declining NLRP3 inflammasomes.
    Lang Y; Chu F; Liu L; Zheng C; Li C; Shen D; Liu S; Zhang W; Cui L; Zhu J
    Clin Exp Immunol; 2022 May; 207(3):378-386. PubMed ID: 35553640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The roles of macrophages and microglia in multiple sclerosis and experimental autoimmune encephalomyelitis.
    Chu F; Shi M; Zheng C; Shen D; Zhu J; Zheng X; Cui L
    J Neuroimmunol; 2018 May; 318():1-7. PubMed ID: 29606295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TRPM2 Exacerbates Central Nervous System Inflammation in Experimental Autoimmune Encephalomyelitis by Increasing Production of CXCL2 Chemokines.
    Tsutsui M; Hirase R; Miyamura S; Nagayasu K; Nakagawa T; Mori Y; Shirakawa H; Kaneko S
    J Neurosci; 2018 Sep; 38(39):8484-8495. PubMed ID: 30201769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Piperlongumine attenuates experimental autoimmune encephalomyelitis through inhibition of NF-kappaB activity.
    Gu SM; Yun J; Son DJ; Kim HY; Nam KT; Kim HD; Choi MG; Choi JS; Kim YM; Han SB; Hong JT
    Free Radic Biol Med; 2017 Feb; 103():133-145. PubMed ID: 28011150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ketogenic diet attenuates neuroinflammation and induces conversion of M1 microglia to M2 in an EAE model of multiple sclerosis by regulating the NF-κB/NLRP3 pathway and inhibiting HDAC3 and P2X7R activation.
    Sun W; Wang Q; Zhang R; Zhang N
    Food Funct; 2023 Jul; 14(15):7247-7269. PubMed ID: 37466915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. S100A4 promotes experimental autoimmune encephalomyelitis by impacting microglial inflammation through TLR4/NF-κB signaling pathway.
    Jingjing H; Tongqian W; Shirong Y; Lan M; Jing L; Shihui M; Haijian Y; Fang Y
    Int Immunopharmacol; 2024 Dec; 142(Pt A):112849. PubMed ID: 39241524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigallocatechin-3 gallate regulates macrophage subtypes and immunometabolism to ameliorate experimental autoimmune encephalomyelitis.
    Cai F; Liu S; Lei Y; Jin S; Guo Z; Zhu D; Guo X; Zhao H; Niu X; Xi Y; Wang Z; Chen G
    Cell Immunol; 2021 Oct; 368():104421. PubMed ID: 34385001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Irgm1 is required for the inflammatory function of M1 macrophage in early experimental autoimmune encephalomyelitis.
    Xu Y; He Z; Li Z; Fang S; Zhang Y; Wan C; Ma Y; Lin P; Liu C; Wang G; Li R; Zhu J; Li Y; Mu L; Zhang Y; Wang J; Kong Q; Li H; Sun B
    J Leukoc Biol; 2017 Feb; 101(2):507-517. PubMed ID: 27443879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fasudil mediates cell therapy of EAE by immunomodulating encephalomyelitic T cells and macrophages.
    Liu CY; Guo SD; Yu JZ; Li YH; Zhang H; Feng L; Chai Z; Yuan HJ; Yang WF; Feng QJ; Xiao BG; Ma CG
    Eur J Immunol; 2015 Jan; 45(1):142-52. PubMed ID: 25287052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral administration of triptolide ameliorates the clinical signs of experimental autoimmune encephalomyelitis (EAE) by induction of HSP70 and stabilization of NF-kappaB/IkappaBalpha transcriptional complex.
    Kizelsztein P; Komarnytsky S; Raskin I
    J Neuroimmunol; 2009 Dec; 217(1-2):28-37. PubMed ID: 19796825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.